Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02543320 · ClinicalTrials.gov registry record · NA

Neurofeedback in Decreasing Acute Radiotherapy-Induced Pain in Patients With Head and Neck Cancer

A NA study of Head and Neck Carcinoma, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
17
Enrollment target
1
Study location

NCT02543320 is a NA study of Head and Neck Carcinoma that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 17 participants, below the 413-participant average among 30 other Head and Neck Carcinoma trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02543320, a NA study of Head and Neck Carcinoma, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
17 participants
Enrollment target
1
Study location

Study Summary

This pilot trial studies how well neurofeedback training works in decreasing acute radiotherapy-induced pain in patients with head and neck cancer. Neurofeedback training is a type of therapy that uses electroencephalograph and a computer software program to measure brain wave activity. Neurofeedback training may help teach patients ways to modify their own brain waves to decrease the perception of pain and improve quality of life.

Conditions Studied

Interventions

  • OTHER Questionnaire Administration
  • OTHER LORETA Neurofeedback Training

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2012-08-29
Est. Completion 2027-04-30
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT02543320

The ClinicalTrials.gov registry entry for NCT02543320 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 413-participant average among 30 other Head and Neck Carcinoma trials with a reported enrollment target (96% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Head and Neck Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.

NCT02543320 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02543320 about?

NCT02543320 is a clinical study titled "Neurofeedback in Decreasing Acute Radiotherapy-Induced Pain in Patients With Head and Neck Cancer". This pilot trial studies how well neurofeedback training works in decreasing acute radiotherapy-induced pain in patients with head and neck cancer. Neurofeedback training is a type of therapy that uses electroencephalograph and a computer software program to measure brain wave activity. Neurofeedbac...

What is the current status of trial NCT02543320?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 17 participants. The study started on 2012-08-29. Estimated completion is 2027-04-30.

What conditions does trial NCT02543320 study?

This clinical trial studies the following conditions: Head and Neck Carcinoma.

What interventions are being tested in trial NCT02543320?

The interventions under investigation include: Questionnaire Administration (OTHER), LORETA Neurofeedback Training (OTHER).

Who is sponsoring clinical trial NCT02543320?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02543320 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.